#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine carcinoma metastatic Chronic hepatitis B Hyperphagia Primary myelofibrosis Adrenocortical carcinoma Rhabdomyosarcoma recurrent Malignant fibrous histiocytoma Sickle cell disease Kaposi's sarcoma Malignant melanoma Granulomatosis with polyangiitis Alexander disease Ehlers-Danlos syndrome Intracranial germ cell tumour Chronic inflammatory demyelinating polyradiculoneuropathy More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis Optic glioma – Life with Disease Small intestine leiomyosarcoma – Diagnostics Myelodysplastic syndrome – Life with Disease Ewing’s sarcoma recurrent – Basic Information Angelman’s syndrome – Treatment Waldenstrom’s macroglobulinaemia – Life with Disease Pelizaeus-Merzbacher disease – Basic Information Ewing’s sarcoma metastatic – Basic Information Angiosarcoma non-metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TTX-381 Sulfonamides, Urea Derivatives Amlitelimab Nifedipine Felis Domesticus (555) LY3537021 Dexibuprofen Gebasaxturev Ciprofloxacin Elacestrant Dihydrochloride Hydroxypropylbetadex Diclofenac Epolamine Timbetasin Acetate Disodium Levofolinate Fremanezumab Tacrolimus Monohydrate Patiromer FLUORIDE Tianeptine Sodium Phenylephrine Hydrochloride More therapies…

    Learn about Your Condition

    Fibrous dysplasia of bone Diffuse large B-cell lymphoma Head and neck cancer Mitochondrial myopathy Pituitary tumour benign Biopsy heart Pancreatic fistula Extra-osseous Ewing's sarcoma Abdominal infection Hepato-lenticular degeneration Hypochromic anaemia Meniere's disease Mesothelioma Embolic stroke Proteinuria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benralizumab
    France The Netherlands Poland

  • Study of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    • Apixaban
    Bulgaria Romania

  • Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone Acetate
    Germany

  • A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ro7589655
    • Simoctocog Alfa
    Austria Denmark France Germany Hungary Italy +3

  • Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Emicizumab
    • Ro7589655
    Austria Belgium Denmark France Germany Hungary +5

  • Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dyslipidaemia
    Investigated Drugs:
    • Bempedoic Acid
    • Obicetrapib
    Czechia Germany Italy The Netherlands Poland Slovakia +1
1 2 3 … 91
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!